LAS VEGAS, NV – October 30, 2023 – As the global health ingredients sector gathered at SupplySide West 2023 in Las Vegas, one company distinguished itself among more than 1,400 exhibitors by setting a new benchmark for functional citrus pectin. Zhejiang Gold Kropn Biotechnology Co., Ltd. (Gold Kropn), prominently featured at booth 4449, presented its flagship innovation: Modified Citrus Pectin (MCP) manufactured through proprietary biological enzymolysis technology. The company's showcase underscored a pivotal industry shift-from generic food additives toward high-value, scientifically substantiated functional ingredients.
SupplySide West, the foremost event for health and nutrition professionals, drew over 18,000 attendees this year, with a pronounced focus on "active nutrition" and clean-label sourcing. Against this backdrop, Gold Kropn attracted considerable interest from leading North American supplement manufacturers. The appeal extended beyond the product itself to the company's unique manufacturing capability: Gold Kropn operates Asia's first and only dedicated production line for low-molecular-weight MCP, with an annual output of 120 tons. This industrial-scale capacity addresses a key challenge for global brands: securing a stable, consistent supply of high-efficacy MCP that meets pharmaceutical-grade standards.
Diverging from traditional pectin producers that depend on acid hydrolysis-a process that can compromise bioactive structures-Gold Kropn employs a patented enzymatic extraction method (Patent ZL 2013 1 0380333.7). "Our technology enables precise shearing of pectin molecules into a targeted molecular weight range of 3,000–15,000 Daltons, while preserving the galactose-rich side chains critical for bioactivity," a company spokesperson explained at the event. This technical distinction is vital for B2B buyers seeking ingredients that deliver genuine differentiation in a competitive marketplace.
Gold Kropn's participation also reinforced the strength of the "China Pharmaceutical Ingredients Brand Pavilion," organized by CCMHPIE, where the company was highlighted as an elite enterprise. By adhering to 100,000-grade GMP purification standards and guaranteeing zero additives, Gold Kropn demonstrated how Chinese biotech innovation is leading the way in quality and purity.
For industry partners, Gold Kropn's message at SupplySide West was unequivocal: the future of advanced pectin lies in enzymatic modification-and a reliable partner is already delivering it. With a robust portfolio that includes patents for anti-tumor and alcohol metabolism support applications, Gold Kropn is positioned to become the strategic supplier of choice for premium health brands worldwide.
About Zhejiang Gold Kropn Biotechnology Co., Ltd.
Based in the Donggang Economic Development Zone, Quzhou, Zhejiang, Gold Kropn is a high-tech enterprise specializing in the R&D, production, and sales of innovative health ingredients. The company holds multiple national patents and collaborates closely with leading institutions, including Zhejiang University, to advance the science and application of Modified Citrus Pectin.